Inhomogeneities in herbal mixtures: a serious risk for consumers

Forensic Toxicology

Volumn 33, Issue 1, 2015, Pages 54-60

  Moosmann, Bjoern ^a,b   Angerer, Verena ^a,b   Auwärter, Volker ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cannabinoid receptor agonist; GC MS; HPLC DAD; Inhomogeneity of herbal mixture; Legal highs; Synthetic cannabinoid

Indexed keywords

CANNABINOID RECEPTOR AGONIST; HERBACEOUS AGENT;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIODE ARRAY DETECTION; HEALTH HAZARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALIZATION; INHOMOGENEITY; INTOXICATION; MASS FRAGMENTOGRAPHY; PACKAGING; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PRODUCT SAFETY; QUANTITATIVE ANALYSIS;

EID: 84922094583     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-014-0247-4     Document Type: Article

References (19)

1. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreiros N (2009) ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832–837
2. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2009) Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61–66
3. European Monitoring Centre for Drugs and Drug Addiction (2012) The state of the drugs problem in Europe, annual report 2012. Publications Office of the European Union, Lisbon
4. European Monitoring Centre for Drugs and Drug Addiction (2014) European drug report 2014: trends and developments. Publications Office of the European Union, Lisbon
5. Langer N, Lindigkeit R, Schiebel HM, Ernst L, Beuerle T (2014) Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures: a snapshot of the German situation in the autumn of 2012. Drug Test Anal 6:59–71
6. Choi H, Heo S, Choe S, Yang W, Park Y, Kim E, Chung H, Lee J (2013) Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC–MS. Anal Bioanal Chem 405:3919–3963
7. Logan BK, Reinhold LE, Xu A, Diamond FX (2012) Identification of synthetic cannabinoids in herbal incense blends in the United States. J Forensic Sci 57:1168–1180
8. Shanks KG, Dahn T, Behonick G, Terrell A (2012) Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. J Anal Toxicol 36:360–371
9. Kneisel S, Bisel P, Brecht V, Broecker S, Müller M, Auwärter V (2012) Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures. Forensic Toxicol 30:126–134
10. Moosmann B, Kneisel S, Girreser U, Brecht V, Westphal F, Auwärter V (2012) Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC–MS, NMR analysis and a flash chromatography system. Forensic Sci Int 220:e17–e22
11. Moosmann B, Kneisel S, Wohlfarth A, Brecht V, Auwärter V (2013) A fast and inexpensive procedure for the isolation of synthetic cannabinoids from ‘Spice’ products using a flash chromatography system. Anal Bioanal Chem 405:3929–3935
12. Huppertz LM, Kneisel S, Auwärter V, Kempf J (2014) A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization. J Mass Spectrom 49:117–127
13. United Nations Office on Drugs and Crime (2013) Recommended methods for the identification and analysis of synthetic cannabinoid agonists in seized materials. UNODC, Vienna
14. Cayman Chemical (2014) Cayman Spectral library. Accessible via https://www.caymanchem.com/app/template/SpectralLibrary.vm. Accessed June 2014
15. Makriyannis A, Deng H (2007) Cannabimimetic indole derivates. A., US Patent No. 7,241,799
16. Huffman JW, Padgett LW (2005) Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. Curr Med Chem 12:1395–1411
17. Frost JM, Dart MJ, Tietje KR, Garrison TR, Grayson GK, Daza AV, El-Kouhen OF, Yao BB, Hsieh GC, Pai M, Zhu CZ, Chandran P, Meyer MD (2009) Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB2 cannabinoid receptor activity. J Med Chem 53:295–315
18. Wiley JL, Marusich JA, Lefever TW, Grabenauer M, Moore KN, Thomas BF (2013) Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles. Neuropharmacology 75:145–154
19. Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR (2006) 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorg Med Chem Lett 16:5432–5435